Leidos HoldingsLDOS
Recorded

Leidos Holdings 2026 Q3 Earnings Call

Review the key takeaways and the transcript of this earnings call.

PeriodQ3 2026Duration1 hr 1 minParticipants14

Transcript

Preview the first fifteen paragraphs, organized by speaker.

Operator

Greetings. Welcome to Leidos' third quarter 2026 earnings conference call. A brief question and answer session will follow the formal presentation. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during this session, you will need to press star 11 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press star 11 again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your first speaker, Stuart Davis, from Investor Relations.

Stuart DavisSVP of Investor Relations

Stuart, please go ahead. Good morning, and welcome to our third quarter 2026 earnings conference call.

Stuart DavisSVP of Investor Relations

The presentation slides we will be using are on our investor relations website. Turning to slide 2, today's discussion contains forward-looking statements based on the environment as we currently see it, and thus includes risks and uncertainties. Today's press release contains more information on specific risk factors that could cause actual results to differ materially. Finally, on slide 3, we will discuss GAAP and non-GAAP financial measures. A reconciliation between the two is included in today's press release and presentation slides. With that, I will turn the call over to CEO Tom Bell, who will begin on slide 4.

Tom BellCEO

Thank you, Stuart, and good morning, everyone. I am glad you could join us on this U.S. election day to review another strong quarter at Leidos. Revenue grew 4%. Adjusted EBITDA improved to 13.9%. Non-GAAP diluted EPS increased 19% year-over-year, and free cash flow was $476 million in the quarter. I will note here that this quarter's cash performance already brings our year-to-date cash flow to $1.5 billion, surpassing our original full-year target. Net awards totaled $5.5 billion, a book-to-bill ratio of 1.2x, and in defense and homeland, two of our growth drivers, book-to-bill was significantly above that. This performance allows us to once again enhance our 2026 guidance for the year. Our sustained momentum in 2026 reflects the strength of our focused team, united behind our NorthStar 2030 strategy and committed to delivering on our customers' most critical missions.

Tom BellCEO

Let me highlight a few examples of our NorthStar strategy in action this quarter. First, we are continuing to sharpen our portfolio. We closed our joint venture combining our Security Enterprise Solutions business with Analogic. The new JV is now a scaled market leader, well-positioned to grow in the $5 billion global security products market. Leidos maintains a significant equity share in this JV, so our shareholders will share in the venture's long-term upside. It also lets us focus our people and our investments where they create the most value under our NorthStar 2030 strategy. Second, we are continuing to move quickly in this market with outcome-based commercial offerings. This is a clear mandate from this administration, and I believe it is a lasting change in how our customers will buy. It is also a strong fit for what Leidos does best.

Tom BellCEO

In health, where we appreciate the military and veteran healthcare mission end-to-end, we are applying our unparalleled customer knowledge to proactively build solutions for emerging customer needs, opening up new growth opportunities for Leidos. My Service Treatment Record, MySTR for short, is a great example. We launched MySTR well before the President's September 8th executive order on veterans' benefits and employment, because we saw the need coming. MySTR is now in beta test, and we are working toward contract award and full customer rollout. As MySTR will run in the customer's cloud, we also look forward to adding new capabilities and functionality over time. Military OneSource is another health example. Our earlier investments in case management technology and provider networks allowed us to stand up a global support operation for Military OneSource in just 75 days. Military OneSource now serves nearly 5 million service members and their families.

Tom BellCEO

That is what it looks like to build once and reuse at scale. In intelligence, we are building a portfolio of commercial cyber and AI products. Parcata, unveiled in July, is the furthest along. It is an automated cybersecurity platform that finds software vulnerabilities across enterprise networks and fixes them without manual intervention. It completes the whole AI-powered patching process in minutes, far faster than existing options. Today, Parcata is focused on our intelligence community's needs. We expect to make Parcata more widely and commercially available later this year. We are also investing in an exciting, robust new technology foundation for everything Leidos develops. Our CTO, Ted Tanner, is leading this effort that builds on the same core Leidos capabilities demonstrated in the real world at Operation Jailbreak and now also at Operation Reveille Forge. This new Leidos technology foundation will allow hardware, software, products, and services to be seamlessly woven together.

Tom BellCEO

This will serve our customers and help Leidos win in ways we believe few customers and competitors can match. Third, our defense tech business is now consistently winning. This business of ours is truly in a unique space where we are increasingly seen as a mature disruptor, pairing our differentiated technology with Leidos' scale, mission expertise, software strength, and delivery track record. This is translating into winning now because our customers simply want it all, fast innovation in a partner they know can integrate, produce, and deliver at scale.

Tom BellCEO

This quarter alone in defense, we won another major contract on the Space Development Agency's AMDT3 program for advanced infrared space sensing payloads, several OTAs for munitions, including a new Air Force Special Operations Command production award for Havoc Spear, and follow-on contracts for the Navy's nuclear-armed SLCM-N program, and a large contract to begin production of a new Army program that builds on our already unrivaled suite of passive sensing solutions. This translated into a defense book-to-bill ratio of 1.9 this quarter and 2.0 year-to-date. This gives us the foundation for revenue growth and margin expansion for years to come. Fourth, energy is rapidly integrating and scaling into a market leader. SkyWire, which we launched earlier, makes electric power distribution engineering more efficient, and it is foundational to our opportunity here, and another example of commercial offerings.

Tom BellCEO

We've now created sister AI-powered tools for gas and power generation projects. As a result, we're actively pursuing a large number of new projects in a larger addressable market, including opportunities in data centers around the nation. We're also actively positioning to meet the growing need for stronger grid cybersecurity. Our path to double-digit revenue growth and mid-to-high teens margin in energy gets clearer every day. In summary, these four examples show the deliberate portfolio choices we're making as a part of NorthStar 2030. We're investing where our capabilities truly stand out and building repeatable commercial offerings. That's NorthStar 2030 in action, and it's how we're positioning Leidos to perform through the rest of this decade. Now, before I turn the call over to Chris, I'd like to share a few words on the VBA MDE recompete.

Tom BellCEO

As this competition is now active and the RFP is still in draft, I'll obviously be somewhat reserved. First, we expect the final RFP later this month. As such, we believe it's highly likely our existing contracts will be extended through the first half of 2027, in line with the customer's planned new contract start date of July 1, 2027. Second, we will, of course, be putting our best foot forward to win. We've always been committed to value, veteran experience, and quality, and these are the things that the VBA focuses on. The draft RFP also clearly recognizes the value of demonstrated performance. So, I continue to see significant upside in Leidos for our investors as we keep executing our NorthStar 2030 strategy. As such, you can expect us to continue to invest in our differentiated capabilities and deploy capital strategically to accelerate growth and create lasting value.

Tom BellCEO

I look forward to your questions after Chris walks through the numbers.

Chris CageCFO

Chris? Thank you, Tom. Let's jump right into the results on slide 5.

Chris CageCFO

Revenue for the quarter was $4.63 billion, up 4% in total and 1% organically year-over-year. Bottom line performance remains strong. Adjusted EBITDA was $644 million for the third quarter, for an adjusted EBITDA margin of 13.9%, up 10 basis points both sequentially and year-over-year. Non-GAAP diluted EPS grew 19% year-over-year to $3.62. Cash performance was a noteworthy highlight. In the quarter, we generated $523 million of cash flows from operating activities and $476 million of free cash flow. That comes to a free cash flow yield of 105% for the quarter and 121% over the trailing 12 months. Let me work through some of the details. First, as expected, our results were materially shaped by the recent changes on our VBA disability exam contract.

Chris CageCFO

Excluding our health segment, which was fundamentally driven by the VBA, revenues grew 9% and non-GAAP operating income grew 48% for the rest of Leidos. We've been on a journey to diversify the earnings power of the company, so it's great to see that show up in the results. In addition, our entire team acted with urgency around cost control, which substantially drove margin and earnings, though it put downward pressure on our growth rate on cost-plus contracts. Second, our team has worked hard on tax optimization strategies to reduce cash taxes and leave more cash available to invest in the business. This quarter's non-GAAP effective tax rate of 15.1% reflects some non-recurring pickups on state taxes, as well as a new approach to calculating our research tax credit that was reviewed and accepted by the IRS.

FULL TRANSCRIPT

Continue the full translated transcript in StockNow.

Log in to unlock every statement, the English original, and speaker-by-speaker history.

Log in for the full transcript

Other earnings calls that day

View calls from this day